⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Consult your healthcare provider before starting any medication. This article is for informational purposes only.
Not all doctors in India are equally familiar with GLP-1 receptor agonists. Semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro) were only recently approved and stocked widely in India. Many general practitioners (GPs) and even some diabetologists trained before GLP-1 medications were a standard treatment tool. Finding a doctor who understands these medications — and knowing when and how to get a second opinion — can significantly affect your treatment outcomes.
This guide helps you navigate India's healthcare system to get the best GLP-1 care available.
The difference between a GLP-1-experienced doctor and one who is not can mean:
A doctor who says "just try it and see" without a follow-up plan, or who dismisses side effects with "it'll pass," may not be giving you the best care.
In India, GLP-1 medications require a prescription. The following specialists are trained to prescribe them:
Endocrinologist: The gold standard for GLP-1 prescribing. Endocrinologists manage hormonal conditions including diabetes and obesity. They are most familiar with GLP-1 titration, side effect management, and combination therapy.
Diabetologist: A physician with specialisation or fellowship in diabetes management. In India, many diabetologists have extensive GLP-1 experience, particularly in metro cities. The RSSDI (Research Society for the Study of Diabetes in India) trains and certifies diabetologists.
Internal Medicine Specialist / General Physician: Many experienced GPs in urban areas are comfortable prescribing semaglutide and tirzepatide, especially for their long-term patients. The quality varies significantly.
Bariatric Physician / Obesity Medicine Specialist: An emerging specialty in India. Particularly relevant if your primary goal is weight loss rather than diabetes management.
Who NOT to get GLP-1 from (without specialist backup):
Hospital Outpatient Departments (OPDs): Large hospitals in India's metro cities have endocrinology departments that are excellent and GLP-1-familiar:
For smaller cities, a government medical college's medicine department is often the best option.
RSSDI (Research Society for the Study of Diabetes in India): The RSSDI website has a member directory and organises certified diabetologist training. Doctors listed as RSSDI members are usually diabetes-literate and aware of current GLP-1 protocols.
Telemedicine platforms:
Word of mouth and patient communities:
A good first GLP-1 consultation in India should include:
History taking:
Baseline investigations they should request (or review if recent):
Prescription:
Follow-up plan:
Red flags in a consultation:
A second opinion is appropriate when:
How to get a second opinion without conflict:
Request your records: In India, you have the right to your medical records. Ask for your consultation notes, investigation reports, and prescription history. Most private hospitals will provide these. Government hospitals may require an RTI application in some cases.
Frame it professionally: You do not need to mention the second opinion to your current doctor. Simply tell a new doctor "I am on semaglutide/tirzepatide and would like a review of my current treatment plan."
Bring everything: Bring all past lab reports, your current prescription, a list of all other medications (including supplements and Ayurvedic), and a timeline of your symptoms and dose changes.
Telemedicine is ideal for second opinions: It is faster, cheaper, and allows you to consult a specialist in a different city. Doctors on telemedicine platforms are often more willing to review cases from other physicians.
AIIMS telemedicine portal: AIIMS Delhi operates a telemedicine portal (esanjeevani.mohfw.gov.in) that allows free consultations with government doctors including endocrinologists, for patients across India.
Write these down and bring them to your appointment:
Do not self-titrate: If your doctor prescribed 0.5 mg semaglutide and you increase it yourself based on online advice, you risk severe side effects and your doctor is unable to properly track your response.
Do not buy from unverified sources: Counterfeit semaglutide is a growing problem in India. Purchase only from licensed pharmacies with a valid prescription. Verify the pen's security features (scratch-off code on Novo Nordisk products, unique lot number).
Do not compare progress with others: Your friend may lose 5 kg in the first month while you lose 1 kg. Individual response varies enormously based on genetics, insulin resistance, diet, and starting dose. Your doctor's job is to optimise your treatment, not to match someone else's results.
Do not stop without telling your doctor: If side effects make you want to stop, contact your doctor first. A dose reduction, a temporary pause, or anti-nausea support may resolve the issue. Abrupt stopping is rarely necessary.
| Setting | Consultation Type | Approximate Cost |
|---|---|---|
| Government hospital OPD | In-person | Rs. 0–100 |
| Private hospital OPD | In-person | Rs. 500–2,000 |
| Senior private endocrinologist | In-person | Rs. 800–3,000 |
| Telemedicine (Practo/Apollo) | Video | Rs. 300–1,500 |
| eSanjeevani (Govt portal) | Video | Free |
Remember that the cost of a proper consultation is small compared to months of suboptimal treatment.
Seek immediate medical attention if you experience:
Consult your healthcare provider before starting any medication. Do not self-medicate or self-titrate GLP-1 medications.
